07.04.2014 • NewsArkemaDede WillamsKem One

Kem One Converting Lavera PVC Site to Membrane Process

French PVC producer Kem One, the former Arkema subsidiary recently rescued from bankruptcy by private equity investor OpenGate Capital and industrialist Alain de Krassny, has begun revamping feedstock production at its Lavera, France, site.

The conversion process, which is receiving financial support from the French government, is expected to be completed by 2016.

Kem One said it is converting its chlorine electrolysis production from the mercury process currently used to the membrane process in order to comply with the European directive to phase out the mercury technology by the end of 2019.

The company did not quantify the cost of the process switch, but described it as "a major investment." Along with improving product quality, the investment also is expected to significantly reduce energy consumption and reduce the environmental footprint of the Lavera site, said de Krassny, who is president of Kem One.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.